Biomotum
PrivateLast Round
Grant
Jul 12, 2023
Total Funding Raised
$4.78M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Biomotum operates in Healthcare & Life Sciences and is based in Portland, Oregon. Its latest recorded funding round was a Grant round in July 2023.
Biomotum is a medical device company that develops and manufactures robotic exoskeletons designed for rehabilitation and mobility assistance.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Industrial Robotics, Health IoT
Business Model
B2B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biomotum Comparables
Compare Biomotum with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NextStep Robotics | 88% | |
| ABLE Human Motion | 81% | |
| Prosperous Robotics | 78% |
For institutional investors. Book with your work email.
Biomotum Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 12, 2023 | ||||
| Grant | Jul 11, 2022 | ||||
| Angel | May 26, 2022 | ||||
| Grant | Dec 1, 2021 | ||||
| Grant | Sep 1, 2021 | ||||
Grant | Jul 20, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Biomotum Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bend Venture Conference | Seed |
| Angel Oregon Life and Bioscience Fund | Angel |
| NIH RADx | Grant |
| Oregon Growth Board | Seed |
| Oregon Community Foundation | Angel |
| Arizona Commerce Authority | Grant |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 87% MoM, reaching 2.1K.
- Jul 12, 2023
$274K grant from NIH RADx and NICHD.
For institutional investors. Book with your work email.
Biomotum Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biomotum's valuation, stock price, and market status.
Is Biomotum a public or private company?
Biomotum is a private company.
What is the current stock price of Biomotum?
Biomotum is a private company, so its shares have no public market price. Caplight tracks Biomotum's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biomotum worth (valuation)?
Valuation information for Biomotum is not publicly available.
Can I buy Biomotum stock?
Biomotum shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biomotum's last funding round?
Biomotum's most recent funding round was Grant on July 12, 2023.
Who are the main investors in Biomotum?
Key investors in Biomotum include Bend Venture Conference, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Will Biomotum IPO soon?
No public IPO plans have been announced for Biomotum.
How can I track Biomotum secondary market activity?
Caplight tracks bids, offers, and trades in Biomotum's shares on secondary markets.